tiprankstipranks
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
US Market

Mirum Pharmaceuticals (MIRM) Income Statement

Compare
679 Followers

Mirum Pharmaceuticals Income Statement

Last quarter (Q4 2024), Mirum Pharmaceuticals's total revenue was $99.41M, an increase of 42.93% from the same quarter last year. In Q4, Mirum Pharmaceuticals's net income was $-23.79M. See Mirum Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 336.89M$ 186.37M$ 77.06M$ 19.14M$ 0.00
Gross Profit
$ 255.25M$ 139.34M$ 64.69M$ 17.23M$ -623.00K
Operating Expenses
$ 342.85M$ 248.49M$ 195.91M$ 190.65M$ 104.30M
Depreciation and Amortization
$ 23.63M$ 10.83M$ 3.68M$ 975.00K$ 623.00K
EBITDA
$ -48.97M$ -136.49M$ -122.41M$ -65.39M$ -102.31M
Operating Income
$ -87.61M$ -109.15M$ -131.22M$ -173.41M$ -104.30M
Other Income/Expenses
$ 694.00K$ -53.27M$ -10.85M$ 89.46M$ 1.03M
Pretax Income
$ -86.91M$ -162.42M$ -142.07M$ -83.95M$ -103.26M
Net Income
$ -87.94M$ -163.41M$ -135.66M$ -83.99M$ -103.27M
Per Share Metrics
Basic EPS
$ -1.85$ -4.00$ -4.01$ -2.77$ -4.09
Diluted EPS
$ -1.85$ -4.00$ -4.01$ -2.77$ -4.09
Weighted Average Shares Outstanding
47.52M 40.89M 33.84M 30.32M 25.25M
Weighted Average Shares Outstanding (Diluted)
47.52M 40.89M 33.84M 30.32M 25.25M
Currency in USD

Mirum Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis